A new report from the Centers for Disease Control and Prevention highlights a dramatic increase in a dangerous type of drug-resistant bacteria called NDM-producing carbapenem-resistant Enterobacterales, or NDM-CRE.
The report, titled 'Changes in Carbapenemase-Producing Carbapenem-Resistant Enterobacterales, 2019 to 2023', was published in the Annals of Internal Medicine. It says, between 2019 and 2023, NDM-CRE infections surged by more than 460 percent in the United States. These infections — including pneumonia, bloodstream infections, urinary tract infections, and wound infections — are extremely hard to treat and can be deadly. Detection is also challenging, as many clinical laboratories lack the necessary testing capacity.
by Joji Xavier
For comments and feedback: contact editorial@rttnews.com